DK176776B1 - Enteriske fluoxetin-piller - Google Patents

Enteriske fluoxetin-piller Download PDF

Info

Publication number
DK176776B1
DK176776B1 DK199800728A DK72898A DK176776B1 DK 176776 B1 DK176776 B1 DK 176776B1 DK 199800728 A DK199800728 A DK 199800728A DK 72898 A DK72898 A DK 72898A DK 176776 B1 DK176776 B1 DK 176776B1
Authority
DK
Denmark
Prior art keywords
fluoxetine
layer
enteric
pill
hpmcas
Prior art date
Application number
DK199800728A
Other languages
Danish (da)
English (en)
Inventor
Roger Garrick Harrison
Daniel Frederick Lynch
Peter Lloyd Oren
Niel Robert Anderson
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25349313&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK176776(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of DK176776B1 publication Critical patent/DK176776B1/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
DK199800728A 1997-05-29 1998-05-28 Enteriske fluoxetin-piller DK176776B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86719697 1997-05-29
US08/867,196 US5910319A (en) 1997-05-29 1997-05-29 Fluoxetine enteric pellets and methods for their preparation and use

Publications (1)

Publication Number Publication Date
DK176776B1 true DK176776B1 (da) 2009-08-10

Family

ID=25349313

Family Applications (1)

Application Number Title Priority Date Filing Date
DK199800728A DK176776B1 (da) 1997-05-29 1998-05-28 Enteriske fluoxetin-piller

Country Status (46)

Country Link
US (3) US5910319A (tr)
JP (1) JP3210288B2 (tr)
KR (1) KR100549473B1 (tr)
CN (2) CN1161109C (tr)
AR (1) AR011728A1 (tr)
AT (1) AT408068B (tr)
AU (1) AU726690B2 (tr)
BE (1) BE1011925A3 (tr)
BR (1) BR9801989A (tr)
CA (1) CA2234826C (tr)
CH (1) CH693018A5 (tr)
CO (1) CO4940407A1 (tr)
CZ (1) CZ290582B6 (tr)
DE (1) DE19823940B4 (tr)
DK (1) DK176776B1 (tr)
ES (1) ES2161574B1 (tr)
FI (1) FI119971B (tr)
FR (1) FR2763846B1 (tr)
GB (1) GB2325623B (tr)
GR (1) GR980100188A (tr)
HK (1) HK1034902A1 (tr)
HU (1) HUP9800882A3 (tr)
ID (1) ID20343A (tr)
IL (1) IL124073A (tr)
IT (1) ITMI980908A1 (tr)
LT (1) LT4477B (tr)
LU (1) LU90245B1 (tr)
LV (1) LV12176B (tr)
MY (1) MY118139A (tr)
NL (1) NL1009259C2 (tr)
NO (1) NO317743B1 (tr)
NZ (1) NZ330192A (tr)
PE (1) PE75399A1 (tr)
PL (1) PL192293B1 (tr)
PT (1) PT102152B (tr)
RO (1) RO120043B1 (tr)
RS (1) RS49827B (tr)
RU (1) RU2164405C2 (tr)
SE (1) SE522914C2 (tr)
SG (1) SG72805A1 (tr)
SI (1) SI9800128B (tr)
SV (1) SV1998000052A (tr)
TR (1) TR199800937A2 (tr)
TW (1) TWI239838B (tr)
UA (1) UA48193C2 (tr)
ZA (1) ZA983173B (tr)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2752732B1 (fr) * 1996-08-28 1998-11-20 Pf Medicament Forme galenique a liberation prolongee de milnacipran
HU229569B1 (hu) * 1999-05-20 2014-02-28 Elan Pharma Int Ltd Szelektív szerotoninújrafelvétel-gátlók szabályozott kibocsátású többrészecskés kiszerelései
IE990406A1 (en) 1999-05-20 2000-12-27 Elan Corp Plc Multiparticulate controlled release selective serotonin reuptake inhibitor formulations.
ES2162560B1 (es) * 1999-06-25 2002-07-16 Rodriguez Concepcion Pena Uso de fluoxetina, paroxetina y otros isrs para la fabricacion de medicamentos con el fin de aumentar la capacidad de abstenerse de substancias o actividades que crean dependencia.
CA2383785C (en) 1999-09-03 2009-02-17 Eli Lilly And Company Methods of using rapid-onset selective serotonin reuptake inhibitors for treating sexual dysfunction
CN1094347C (zh) * 1999-11-15 2002-11-20 广东药学院药物研究所 一种治疗前列腺良性增生症的控释微丸及其制备方法
US6273260B1 (en) 2000-03-08 2001-08-14 Eli Lilly And Company Pharmaceutical packaging system
ES2185452B2 (es) * 2000-08-01 2004-03-16 Cinfa S A Lab Composicion farmaceutica de fluoxetina en comprimido dispersable recubierto y su proceso de fabricacion.
JP4181738B2 (ja) * 2000-08-25 2008-11-19 信越化学工業株式会社 腸溶性コーティング製剤の製造方法
US6482440B2 (en) * 2000-09-21 2002-11-19 Phase 2 Discovery, Inc. Long acting antidepressant microparticles
WO2002038126A2 (en) * 2000-11-08 2002-05-16 Aeromatic-Fielder Ag A process for production of particles for pharmaceutical compositions having increased bioavailability
WO2003013480A1 (en) 2001-08-06 2003-02-20 Dr. Reddy's Laboratories Ltd. Improved enteric formulation of fluoxetin
US20040170688A1 (en) * 2001-08-06 2004-09-02 Deshmukh Abhijit Mukund Enteric formulation of fluoxetin
US20040220153A1 (en) * 2002-09-24 2004-11-04 Jost-Price Edward Roydon Methods and reagents for the treatment of diseases and disorders associated with increased levels of proinflammatory cytokines
WO2004058228A1 (en) * 2002-12-24 2004-07-15 Lupin Limited Enteric coated fluoxetine composition
US8614247B2 (en) * 2003-04-10 2013-12-24 Institut National De La Sante Et De La Recherche Medicale Methods for preventing, attenuating or treating pulmonary hypertension using a serotonin transporter inhibitor, and pharmaceutical compositions for the treatment thereof
AP2501A (en) 2003-05-30 2012-10-22 Ranbaxy Lab Ltd Substituted pyrrole derivatives
US20050176693A1 (en) * 2003-08-12 2005-08-11 Boissonneault Roger M. Method of intermittent administration of a pharmaceutical for the treatment of conditions associated with a female's menstrual cycle
CA2552440A1 (en) * 2003-12-30 2005-07-21 Dr. Reddy's Laboratories Ltd. Pharmaceutical composition
EP1787640A4 (en) * 2004-04-30 2012-04-11 Astellas Pharma Inc GRAINED PHARMACEUTICAL COMPOSITION WITH TEMPORARY DELIVERY FOR ORAL ADMINISTRATION AND FAST-DECREASING INTRAORAL TABLET WITH THE COMPOSITION
KR100920856B1 (ko) * 2004-11-30 2009-10-09 (주)아모레퍼시픽 선택적 세로토닌 재흡수 억제제의 연장방출 제제 및 그제조방법
WO2006071868A2 (en) * 2004-12-23 2006-07-06 Teva Pharmaceutical Industries Ltd. Process for preparing pharmaceutically acceptable salts of duloxetine and intermediates thereof
JP5153629B2 (ja) * 2005-08-02 2013-02-27 ルピン・リミテッド 選択的セロトニン再取り込み阻害剤の新規の制御放出組成物
US8026377B2 (en) 2005-11-08 2011-09-27 Ranbaxy Laboratories, Limited Process for (3R, 5R)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-[(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3,5-dihydroxy-heptanoic acid hemi calcium salt
AU2006318476A1 (en) * 2005-11-23 2007-05-31 Auspex Pharmaceuticals, Inc. Substituted aryloxypropylamines with serotoninergic and/or norepinephrinergic activity
EP1863782A1 (en) * 2005-12-05 2007-12-12 Teva Pharmaceutical Industries Ltd. 2-(n-methyl-propanamine)-3-(2-naphtol) thiophene, an imputity of duloxetine hydrochloride
MX2008010879A (es) * 2006-02-24 2008-10-27 Teva Pharma Composiciones farmaceuticas de sodio de fluvastatina.
CN101057837B (zh) * 2006-04-20 2010-12-22 湖南九典制药有限公司 一种右旋酮洛芬肠溶微丸及制备方法
WO2007134168A2 (en) * 2006-05-10 2007-11-22 Dr. Reddy's Laboratories Ltd. Process for preparing duloxetine
RU2008148547A (ru) * 2006-05-22 2010-06-27 Тева Фармасьютикл Индастриес Лтд. (Il) Фармацевтические композиции, включающие дулоксетина гидрохлорид с замедленным высвобождением
WO2007138606A2 (en) * 2006-06-01 2007-12-06 Dexcel Pharma Technologies Ltd. Multiple unit pharmaceutical formulation
JP5052051B2 (ja) * 2006-06-16 2012-10-17 トーアエイヨー株式会社 腸溶性顆粒剤及びその製造方法
BRPI0714915A2 (pt) * 2006-07-28 2013-05-28 Reddys Lab Ltd Dr composiÇço farmacÊuticas; formas de dosagem farmacÊutica; e processo para o preparo de uma composiÇço farmacÊutica
US20080033050A1 (en) 2006-08-04 2008-02-07 Richards Patricia Allison Tewe Method of treating thermoregulatory disfunction with paroxetine
WO2008020286A2 (en) * 2006-08-14 2008-02-21 Torrent Pharmaceuticals Limited Pharmaceutical compositions of duloxetine
US20080103105A1 (en) * 2006-09-22 2008-05-01 Braincells, Inc. HMG CoA REDUCTASE MEDIATED MODULATION OF NEUROGENESIS
US20080226711A1 (en) * 2007-03-12 2008-09-18 Torrent Pharmaceuticals Ltd. Pharmaceutical compositions of duloxetine
US20090226517A1 (en) * 2008-02-06 2009-09-10 Vinita Umashankar Vyas Pharmaceutical formulations comprising duloxetine
RS53866B1 (en) 2008-07-16 2015-08-31 Richter Gedeon Nyrt. PHARMACEUTICAL FORMULATIONS CONTAINING DOPAMINE RECEPTOR LIGANDS
WO2010026993A1 (ja) * 2008-09-03 2010-03-11 武田薬品工業株式会社 製剤における吸収性改善方法および吸収性が改善された製剤
CN101804145B (zh) * 2009-02-12 2012-11-14 杭州赛利药物研究所有限公司 一种大蒜油肠溶微丸胶囊及其制备方法
US20120207825A1 (en) * 2009-09-17 2012-08-16 Sunilendu Bhushan Roy Pharmaceutical compositions for reducing alcohol-induced dose dumping
JP5749247B2 (ja) 2010-02-22 2015-07-15 第一三共株式会社 経口用徐放性固形製剤
WO2013164122A1 (en) 2012-05-02 2013-11-07 Capsugel France SAS Aqueous dispersions of controlled release polymers and shells and capsules thereof
CN102716084B (zh) * 2012-06-29 2013-09-25 海南美大制药有限公司 盐酸氟西汀脂质体固体制剂
TWI566786B (zh) 2012-09-03 2017-01-21 第一三共股份有限公司 含有氫化嗎啡酮鹽酸鹽之經口用徐放性醫藥組成物
US20140206667A1 (en) 2012-11-14 2014-07-24 Michela Gallagher Methods and compositions for treating schizophrenia
US9782356B2 (en) 2014-05-20 2017-10-10 Dow Global Technologies Llc Capsule shells comprising an esterified cellulose ether
EP3145498B1 (en) 2014-05-20 2020-03-04 Dow Global Technologies LLC Dispersion comprising a partially neutralized esterified cellulose ether
US10564114B2 (en) * 2014-06-07 2020-02-18 Structure-Ase Incorporated Method for the detection and/or diagnosis of eating disorders and malnutrition using X-ray diffraction
US10471152B2 (en) 2014-08-29 2019-11-12 Capsugel Belgium Nv Colloidal dispersion comprising HPMCAS
US20170042806A1 (en) 2015-04-29 2017-02-16 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
US11274087B2 (en) 2016-07-08 2022-03-15 Richter Gedeon Nyrt. Industrial process for the preparation of cariprazine
US11318122B2 (en) 2017-04-13 2022-05-03 Chase Therapeutics Corporation Pharmaceutical combination and its use for treating synucleinopathties
HUP1700253A1 (hu) 2017-06-13 2019-01-28 Richter Gedeon Nyrt Szilárd orális gyógyszerkészítmények
CN107898942B (zh) * 2017-11-24 2021-01-26 一力制药(罗定)有限公司 一种感冒清热胶囊及其制备方法
US11547707B2 (en) 2019-04-10 2023-01-10 Richter Gedeon Nyrt. Carbamoyl cyclohexane derivatives for treating autism spectrum disorder
WO2022115054A1 (en) * 2020-11-27 2022-06-02 Santa Farma Ilac Sanayii A.S. Enteric coated duloxetine compositions

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4626549A (en) * 1974-01-10 1986-12-02 Eli Lilly And Company Treatment of obesity with aryloxyphenylpropylamines
US4314081A (en) * 1974-01-10 1982-02-02 Eli Lilly And Company Arloxyphenylpropylamines
US4018895A (en) 1974-01-10 1977-04-19 Eli Lilly And Company Aryloxyphenylpropylamines in treating depression
US4194009A (en) 1974-01-10 1980-03-18 Eli Lilly And Company Aryloxyphenylpropylamines for obtaining a psychotropic effect
JPS517116A (en) 1974-06-11 1976-01-21 Shinetsu Chemical Co Choyoseihifukuyakuzaino seizohoho
CH649216A5 (de) 1979-08-16 1985-05-15 Sandoz Ag Verfahren zur auftragung eines magensaftresistenten filmes auf einen heilmittelkern und feste einheitsdosierungsform mit magensaftresistentem film.
JPS5855125B2 (ja) * 1980-03-10 1983-12-08 信越化学工業株式会社 固形薬剤用腸溶性コ−テイング剤組成物
US4444778A (en) * 1981-08-27 1984-04-24 Coughlin Shaun R Method and composition for treating atherosclerosis
US4797286A (en) 1985-11-12 1989-01-10 Eli Lilly And Company Orally administerable sustained release pharmaceutical formulations
US4847092A (en) * 1985-11-12 1989-07-11 Eli Lilly And Company Orally administerable sustained release pharmaceutical formulations
GB2189699A (en) 1986-04-30 1987-11-04 Haessle Ab Coated acid-labile medicaments
US4918242A (en) 1988-03-30 1990-04-17 Aldrich Chemical Company, Inc. Novel optically 1,3-phenoxypropylhalides
CA1337955C (en) * 1988-09-26 1996-01-23 Thomas A. Almquist Recoating of stereolithographic layers
US4999382A (en) * 1988-10-26 1991-03-12 Massachusetts Institute Of Technology Compositions for treating tobacco withdrawal symptoms and methods for their use
US5356934A (en) * 1990-03-29 1994-10-18 Eli Lilly And Company Selected serotonin subtype receptor agonist to treat sleep apnea
US5104899A (en) * 1990-08-13 1992-04-14 Sepracor, Inc. Methods and compositions for treating depression using optically pure fluoxetine
US5589511A (en) * 1990-08-13 1996-12-31 Sepracor Inc. Method for treating migraine headaches using optically pure S(+) fluoxetine
JPH04202124A (ja) * 1990-11-29 1992-07-22 Fuji Kagaku Kogyo Kk 噴霧乾燥造粒法による薬物放出の制御された製剤の製造法
AU1429092A (en) * 1991-02-04 1992-09-07 Timothy J Barberich Methods of use and compositions of r(-) fluoxetine
WO1992019241A1 (en) * 1991-05-07 1992-11-12 Dynagen, Inc. A controlled, sustained release delivery system for smoking cessation
EP0632720B1 (en) * 1992-03-25 1998-11-11 Depomed Systems, Inc. Hydroxyethylcellulose-based sustained-release oral drug dosage froms
US5518730A (en) * 1992-06-03 1996-05-21 Fuisz Technologies Ltd. Biodegradable controlled release flash flow melt-spun delivery system
JPH06293633A (ja) * 1993-04-05 1994-10-21 Shin Etsu Chem Co Ltd 水性腸溶性エマルジョンの製造方法
US5362886A (en) 1993-10-12 1994-11-08 Eli Lilly And Company Asymmetric synthesis
DE69426570T2 (de) * 1993-11-03 2001-08-23 Isomed, Inc. Mizelleförmige feinteilige pharmazeutische zusammensetzungen
CA2134038C (en) * 1994-06-16 1997-06-03 David Taiwai Wong Potentiation of drug response
US5508276A (en) * 1994-07-18 1996-04-16 Eli Lilly And Company Duloxetine enteric pellets
ES2082723B1 (es) * 1994-07-20 1996-10-01 Lilly Sa Formulacion farmaceutica de fluoxetina en forma dispersable.
JPH08109126A (ja) * 1994-10-07 1996-04-30 Amano Pharmaceut Co Ltd 耐衝撃性腸溶性顆粒剤およびこれを含有する錠剤
JPH08245423A (ja) * 1995-03-06 1996-09-24 Shionogi & Co Ltd 水系腸溶性コーティング液
GB9514842D0 (en) * 1995-07-20 1995-09-20 Smithkline Beecham Plc Novel formulation

Also Published As

Publication number Publication date
LV12176A (lv) 1998-12-20
ATA93198A (de) 2001-01-15
RU2164405C2 (ru) 2001-03-27
GB2325623B (en) 1999-04-14
AT408068B (de) 2001-08-27
BR9801989A (pt) 2000-02-08
SE522914C2 (sv) 2004-03-16
USRE39030E1 (en) 2006-03-21
LU90245A1 (tr) 1998-11-30
DE19823940B4 (de) 2010-04-29
CN1285189A (zh) 2001-02-28
CO4940407A1 (es) 2000-07-24
CN1161109C (zh) 2004-08-11
TWI239838B (en) 2005-09-21
LT98058A (en) 1998-10-26
CH693018A5 (de) 2003-01-31
PT102152B (pt) 2000-09-29
RO120043B1 (ro) 2005-08-30
NZ330192A (en) 1999-08-30
AU726690B2 (en) 2000-11-16
JPH10330253A (ja) 1998-12-15
NL1009259C2 (nl) 1998-12-01
FR2763846A1 (fr) 1998-12-04
NO982197D0 (no) 1998-05-14
CN1200924A (zh) 1998-12-09
CZ290582B6 (cs) 2002-08-14
PL326134A1 (en) 1998-12-07
GB2325623A (en) 1998-12-02
SE9801336L (sv) 1998-11-30
ID20343A (id) 1998-12-03
DE19823940A1 (de) 1998-12-03
KR19980086622A (ko) 1998-12-05
TR199800937A3 (tr) 1999-10-21
GB9807939D0 (en) 1998-06-10
NO317743B1 (no) 2004-12-13
HUP9800882A2 (hu) 2000-03-28
AR011728A1 (es) 2000-08-30
RS49827B (sr) 2008-08-07
AU6904898A (en) 1998-12-03
ZA983173B (en) 1999-10-15
JP3210288B2 (ja) 2001-09-17
GR980100188A (el) 1999-01-29
HU9800882D0 (en) 1998-05-28
IE980284A1 (en) 2000-07-12
MY118139A (en) 2004-09-30
IL124073A (en) 2002-02-10
CA2234826C (en) 2000-12-19
KR100549473B1 (ko) 2006-03-23
TR199800937A2 (tr) 1999-10-21
ES2161574B1 (es) 2002-06-16
LU90245B1 (fr) 2002-07-31
HK1034902A1 (en) 2001-11-09
FI980846A (fi) 1998-11-30
SG72805A1 (en) 2000-05-23
US5985322A (en) 1999-11-16
US5910319A (en) 1999-06-08
SE9801336D0 (sv) 1998-04-17
CA2234826A1 (en) 1998-11-29
PL192293B1 (pl) 2006-09-29
PT102152A (pt) 1998-12-31
FR2763846B1 (fr) 2001-05-18
YU16598A (en) 1999-11-22
HUP9800882A3 (en) 2000-07-28
SV1998000052A (es) 1999-03-16
CZ114398A3 (cs) 1998-12-16
SI9800128B (sl) 2000-04-30
FI980846A0 (fi) 1998-04-16
NO982197L (no) 1998-11-30
CN1212834C (zh) 2005-08-03
FI119971B (fi) 2009-05-29
LV12176B (en) 1999-03-20
BE1011925A3 (fr) 2000-03-07
SI9800128A (sl) 1999-02-28
LT4477B (lt) 1999-03-25
ES2161574A1 (es) 2001-12-01
PE75399A1 (es) 1999-08-17
ITMI980908A1 (it) 1999-10-28
UA48193C2 (uk) 2002-08-15

Similar Documents

Publication Publication Date Title
DK176776B1 (da) Enteriske fluoxetin-piller
RU2147231C1 (ru) Кишечные гранулы дульоксетина
US20110052647A1 (en) Antidepressant Oral Pharmaceutical Compositions
CN102772392B (zh) 一种阿比多尔缓控释胶囊及其制备方法
WO2010080970A2 (en) Oral enteric antidepressant formulation
MXPA98003636A (es) Granulos entericos de fluoxetina
IE83510B1 (en) Fluoxetine enteric pellets
EA029916B1 (ru) Таблетка дулоксетина с энтеросолюбильным покрытием
KR20220158703A (ko) 독실아민 석시네이트 및 피리독신 염산염의 변형 방출 다중 단위 경구 제형 및 이의 제조 방법

Legal Events

Date Code Title Description
PUP Patent expired

Expiry date: 20180528